No Evidence of Cognitive Issues When Evolocumab Added to Statin Therapy: ACC 2017 supriya kashyap kashyap29 March 2017 12:45 PM ISTWashington : There is no evidence that adding a new cholesterol-lowering drug to treatment with a statin causes memory loss or other problems with...
LDL-C ≥190 mg/dl is Ideal for Primary Prevention of CAD!! Anjali Nimesh Nimesh25 Sept 2017 11:30 AM ISTIt has been debated every now and then that what is ideal LDL Cholesterol level for primary prevention of Coronary Artery Disease. In case one is...
Subcutaneous injections twice a year - Inclisiran lowers LDL for up to one year (ORION 1) supriya kashyap kashyap6 Oct 2017 11:00 AM ISTBarcelona : Inclisiran lowers low-density lipoprotein (LDL; “bad”) cholesterol for up to one year in patients with high cardiovascular risk and...
How low to go with glucose, cholesterol, and blood pressure in primary prevention of CVD Dr. Kamal Kant Kohli Kohli22 Oct 2017 8:30 PM ISTHong KN et al. in his review article enumerated some points regarding how low to go with glucose, cholesterol, and blood pressure (BP) in primary...
Only 40% of people with dangerously high cholesterol on appropriate drug treatment Dr. Kamal Kant Kohli Kohli26 March 2018 7:02 PM ISTNational Cholesterol Education Program’s Adult Treatment Panel III (ATP-III guidelines) and the current American College of Cardiology and American...
Medical Treatment of Familial Hypercholesterolemia Dr. Kamal Kant Kohli Kohli1 April 2018 7:30 PM ISTFamilial Hypercholesterolemia(FH) is an autosomal dominant genetic disorder thereby meaning that each first-degree relative has a 50% of inheriting...
Win for PCSK9 inhibitors - Alirocumab ODYSSEY OUTCOMES Trial Anjali Nimesh Nimesh7 April 2018 8:00 PM ISTResidual risk of an acute coronary event in a patient of known coronary artery disease remains high despite maximum evidence base preventive therapy....
Alirocumab reduces risk of recurrent MI in ACS patients: ODYSSEY trial Medha Baranwal Baranwal2 Dec 2018 7:28 PM ISTAdministration of alirocumab in patients with a history of an acute coronary syndrome (ACS) and already receiving high-intensity statin therapy,...
Benefit of Statin use persists even beyond 75 years of age: Lancet Hina Zahid31 Jan 2019 8:20 PM ISTAccording to a meta-analysis, more people over the age of 75 should be taking statins. The research has found statins cut the risk of major...
Interruption in statin therapy increases death risk, finds JAMA study Deepanjana Sarkar15 Feb 2019 8:28 PM ISTContinuity is the key, interruption in statin therapy increases death risk, finds a new study.In a cohort study scientists of Stanford University in...
Statins use may increase blood sugar and Diabetes risk Dr. Kamal Kant Kohli Kohli6 March 2019 8:28 PM ISTStatins use may increase blood sugar and Diabetes risk.Patients taking cholesterol-lowering statins may be at higher risk for developing high blood...
New evidence strongly supports statin use for secondary prevention Medha Baranwal Baranwal29 March 2019 8:28 PM ISTDELHI: The role of statin therapy in the prevention of cardiovascular disease has been well received by the medical and scientific communities, with...
